BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9533072)

  • 1. Significance of a tetracycline and Pepto-Bismol interaction in the management of Helicobacter pylori-induced peptic ulcer disease.
    Tkach CL; Ariano RE
    Ann Pharmacother; 1998 Mar; 32(3):387. PubMed ID: 9533072
    [No Abstract]   [Full Text] [Related]  

  • 2. Helicobacter pylori and peptic ulcer disease. Reexamining the therapeutic approach.
    Fedotin MS
    Postgrad Med; 1993 Sep; 94(3):38-40, 43-5. PubMed ID: 8361941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
    Patchin GM; Wieland KA; Carmichael JM
    Am J Health Syst Pharm; 1996 Sep; 53(17):2081-2. PubMed ID: 8991624
    [No Abstract]   [Full Text] [Related]  

  • 4. Treating peptic ulcer: an ongoing challenge.
    Cohen MH
    J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
    [No Abstract]   [Full Text] [Related]  

  • 5. Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease.
    Peura DA; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1137-9. PubMed ID: 8053422
    [No Abstract]   [Full Text] [Related]  

  • 6. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection.
    al-Assi MT; Ramirez FC; Lew GM; Genta RM; Graham DY
    Am J Gastroenterol; 1994 Aug; 89(8):1203-5. PubMed ID: 8053435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease.
    Graham DY; Hepps KS; Ramirez FC; Lew GM; Saeed ZA
    Scand J Gastroenterol; 1993 Nov; 28(11):939-42. PubMed ID: 8284627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eradication of Helicobacter pylori reduces gastric and duodenal ulcer recurrence.
    Laine L
    Gastroenterology; 1992 Nov; 103(5):1695-6. PubMed ID: 1426890
    [No Abstract]   [Full Text] [Related]  

  • 9. Identification and eradication of Helicobacter pylori in an isolated patient population.
    Myers D
    Mil Med; 1997 Jul; 162(7):507-9. PubMed ID: 9232984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the eradication of Helicobacter pylori with triple therapy.
    Graham DY; Lew GM; Malaty HM; Evans DG; Evans DJ; Klein PD; Alpert LC; Genta RM
    Gastroenterology; 1992 Feb; 102(2):493-6. PubMed ID: 1732120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of peptic ulcer and gastritis associated with Helicobacter pylori].
    López-Brea M; Alarcón T
    Enferm Infecc Microbiol Clin; 1995; 13(7):422-8. PubMed ID: 8519820
    [No Abstract]   [Full Text] [Related]  

  • 12. Helicobacter pylori therapy: effect on peptic ulcer disease.
    Axon AT
    J Gastroenterol Hepatol; 1991; 6(2):131-7. PubMed ID: 1912418
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment strategies for Helicobacter pylori infection.
    Damianos AJ; McGarrity TJ
    Am Fam Physician; 1997 Jun; 55(8):2765-74, 2784-6. PubMed ID: 9191460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HELIDAC therapy (bismuth subsalicylate/metronidazole/tetracycline hydrochloride).
    Claussen DW
    Gastroenterol Nurs; 1997; 20(5):188-9. PubMed ID: 9384064
    [No Abstract]   [Full Text] [Related]  

  • 15. H. pylori and ulcers.
    McGuffey EC
    Am Pharm; 1994 Jul; NS34(7):21. PubMed ID: 8085532
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
    Park KN; Hahm JS; Kim HJ
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S103-7. PubMed ID: 7735924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic approaches to recurrent peptic ulcer disease.
    Cave DR
    Hosp Pract (Off Ed); 1992 Sep; 27(9A):33-40, 43, 47-9. PubMed ID: 1522168
    [No Abstract]   [Full Text] [Related]  

  • 18. Azithromycin triple therapy for Helicobacter pylori infection: azithromycin, tetracycline, and bismuth.
    al-Assi MT; Genta RM; Karttunen TJ; Cole RA; Graham DY
    Am J Gastroenterol; 1995 Mar; 90(3):403-5. PubMed ID: 7872278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bismuth subcitrate/metronidazole/ tetracycline--Axcan Pharma. Bismuth triple therapy--Axcan Pharma, Helicide.
    Drugs R D; 2002; 3(6):402-4. PubMed ID: 12516945
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
    García Pérez A; Valverde de La Osa J; Giménez Samper M; Alonso García I
    Sangre (Barc); 1999 Oct; 44(5):387-8. PubMed ID: 10618919
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.